Kane gets DispersinB from biotech plants

Kane Biotech (TSX-V:KNE) has confirmed the invention of biotech plants producing DispersinB antibiofilm enzyme, representing a proof of concept for developing bacterial disease-resistant agricultural crops.

The Company said DispersinB-expressing plants are resistant to plant pathogens due to their ability to inhibit and disrupt biofilms. In addition, this biotech plant can also be used as a bioreactor for commercial scale production of DispersinB enzyme; an alternative to the fermentation process currently used to produce DispersinB.

“This new discovery has applications in preventing major bacterial diseases in crops that involve biofilms which can be up to 1,000 times more resistant to antimicrobials than their planktonic counterparts and has the potential to substantially reduce the agricultural losses in crops such as potatoes, tomatoes and cassava worldwide”, CEO Gord Froehlich said in a statement.